Panagora Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.45M | Buy |
87,088
+17,068
| +24% | +$454K | 0.01% | 548 |
|
|
2025
Q4 | $1.74M | Sell |
70,020
-666
| -0.9% | -$16.8K | 0.01% | 603 |
|
|
2025
Q3 | $1.8M | Buy |
70,686
+27,627
| +64% | +$682K | 0.01% | 544 |
|
|
2025
Q2 | $1.04M | Sell |
43,059
-44,789
| -51% | -$1.04M | ﹤0.01% | 621 |
|
|
2025
Q1 | $2.23M | Buy |
87,848
+3,128
| +4% | +$81.9K | 0.01% | 486 |
|
|
2024
Q4 | $2.25M | Sell |
84,720
-31,218
| -27% | -$847K | 0.01% | 491 |
|
|
2024
Q3 | $3.36M | Buy |
115,938
+35,975
| +45% | +$1.05M | 0.02% | 425 |
|
|
2024
Q2 | $2.24M | Sell |
79,963
-1,976,209
| -96% | -$54.4M | 0.01% | 489 |
|
|
2024
Q1 | $57.1M | Buy |
2,056,172
+276,647
| +16% | +$7.68M | 0.3% | 83 |
|
|
2023
Q4 | $51.2M | Sell |
1,779,525
-740,862
| -29% | -$22.4M | 0.29% | 88 |
|
|
2023
Q3 | $83.6M | Sell |
2,520,387
-129,484
| -5% | -$4.58M | 0.52% | 51 |
|
|
2023
Q2 | $97.2M | Sell |
2,649,871
-794,562
| -23% | -$30.9M | 0.57% | 33 |
|
|
2023
Q1 | $141M | Sell |
3,444,433
-39,856
| -1% | -$1.72M | 0.89% | 13 |
|
|
2022
Q4 | $179M | Buy |
3,484,289
+158,502
| +5% | +$7.6M | 1.17% | 9 |
|
|
2022
Q3 | $146M | Buy |
3,325,787
+137,758
| +4% | +$6.69M | 1.01% | 11 |
|
|
2022
Q2 | $167M | Buy |
3,188,029
+183,858
| +6% | +$9.37M | 1.1% | 11 |
|
|
2022
Q1 | $156M | Buy |
3,004,171
+215,900
| +8% | +$11.2M | 0.85% | 15 |
|
|
2021
Q4 | $165M | Sell |
2,788,271
-3,329
| -0.1% | -$165K | 0.87% | 13 |
|
|
2021
Q3 | $120M | Buy |
2,791,600
+20,978
| +0.8% | +$929K | 0.64% | 25 |
|
|
2021
Q2 | $108M | Buy |
2,770,622
+2,131,900
| +334% | +$82.9M | 0.58% | 29 |
|
|
2021
Q1 | $23.1M | Sell |
638,722
-896,932
| -58% | -$31.8M | 0.13% | 162 |
|
|
2020
Q4 | $56.5M | Sell |
1,535,654
-217,276
| -12% | -$7.97M | 0.33% | 65 |
|
|
2020
Q3 | $61M | Buy |
1,752,930
+1,045,773
| +148% | +$36.7M | 0.38% | 57 |
|
|
2020
Q2 | $21.9M | Sell |
707,157
-152,950
| -18% | -$5.2M | 0.14% | 147 |
|
|
2020
Q1 | $26.6M | Sell |
860,107
-142,475
| -14% | -$4.85M | 0.19% | 119 |
|
|
2019
Q4 | $37.3M | Sell |
1,002,582
-557,734
| -36% | -$19.9M | 0.17% | 134 |
|
|
2019
Q3 | $53.2M | Sell |
1,560,316
-624,126
| -29% | -$22.7M | 0.25% | 101 |
|
|
2019
Q2 | $89.8M | Buy |
2,184,442
+46,977
| +2% | +$1.87M | 0.4% | 60 |
|
|
2019
Q1 | $86.1M | Buy |
2,137,465
+233,891
| +12% | +$9.37M | 0.38% | 64 |
|
|
2018
Q4 | $78.8M | Buy |
1,903,574
+319,026
| +20% | +$13.2M | 0.37% | 65 |
|
|
2018
Q3 | $66.3M | Buy |
1,584,548
+312,361
| +25% | +$12M | 0.25% | 95 |
|
|
2018
Q2 | $43.8M | Buy |
1,272,187
+6,565
| +0.5% | +$224K | 0.17% | 138 |
|
|
2018
Q1 | $42.6M | Sell |
1,265,622
-901,114
| -42% | -$31M | 0.17% | 134 |
|
|
2017
Q4 | $74.5M | Sell |
2,166,736
-1,348,306
| -38% | -$46M | 0.28% | 92 |
|
|
2017
Q3 | $119M | Sell |
3,515,042
-2,513,257
| -42% | -$80.8M | 0.47% | 45 |
|
|
2017
Q2 | $192M | Sell |
6,028,299
-620,539
| -9% | -$19.6M | 0.77% | 21 |
|
|
2017
Q1 | $216M | Buy |
6,648,838
+546,323
| +9% | +$17.2M | 0.9% | 18 |
|
|
2016
Q4 | $188M | Sell |
6,102,515
-747,966
| -11% | -$22.8M | 0.86% | 18 |
|
|
2016
Q3 | $220M | Sell |
6,850,481
-1,116,770
| -14% | -$37.3M | 1.05% | 11 |
|
|
2016
Q2 | $266M | Sell |
7,967,251
-1,004,869
| -11% | -$32.1M | 1.32% | 9 |
|
|
2016
Q1 | $252M | Sell |
8,972,120
-1,376,155
| -13% | -$39.3M | 1.25% | 9 |
|
|
2015
Q4 | $317M | Sell |
10,348,275
-141,434
| -1% | -$4.45M | 1.56% | 3 |
|
|
2015
Q3 | $313M | Buy |
10,489,709
+168,386
| +2% | +$5.4M | 1.65% | 4 |
|
|
2015
Q2 | $328M | Buy |
10,321,323
+328,054
| +3% | +$10.7M | 1.65% | 3 |
|
|
2015
Q1 | $330M | Sell |
9,993,269
-191,600
| -2% | -$6.09M | 1.67% | 2 |
|
|
2014
Q4 | $301M | Sell |
10,184,869
-1,820,663
| -15% | -$52.2M | 1.54% | 5 |
|
|
2014
Q3 | $337M | Buy |
12,005,532
+169,322
| +1% | +$4.75M | 1.63% | 3 |
|
|
2014
Q2 | $333M | Buy |
11,836,210
+1,170,110
| +11% | +$33.4M | 1.62% | 3 |
|
|
2014
Q1 | $325M | Sell |
10,666,100
-848,708
| -7% | -$25.3M | 1.54% | 4 |
|
|
2013
Q4 | $335M | Sell |
11,514,808
-1,050,195
| -8% | -$30.6M | 1.55% | 4 |
|
|
2013
Q3 | $342M | Buy |
12,565,003
+3,256,248
| +35% | +$88.6M | 1.68% | 4 |
|
|
2013
Q2 | $247M | Buy |
+9,308,755
| New | +$257M | 1.27% | 9 |
|
Other funds holding PFE
VCM
VPM
Panagora Asset Management's PFE Position: Q1 2026 in Review
Panagora Asset Management increased its Pfizer (PFE) stake by 24% in Q1 2026, buying an estimated $454K and bringing the position to 87,088 shares worth $2.45M. The position accounts for 0.01% of the portfolio, ranked #548.
Panagora Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $342M in Q3 2013. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Panagora Asset Management held 87,088 shares of Pfizer worth $2.45M as of Q1 2026.
- Panagora Asset Management bought 17,068 Pfizer shares in Q1 2026, an estimated $454K.
- Pfizer made up 0.01% of Panagora Asset Management's portfolio in Q1 2026, its #548 holding.
- Panagora Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Panagora Asset Management's Pfizer position peaked at $342M in Q3 2013.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.